Roi Westreich

Roi Westreich

Auto-generated profile, based on publicly available information

Roi Westreich

Cardiology Department, Soroka University Medical Center , Rager Boulevard, PO Box 151, Beersheba 8410101

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ODO. Deutsch
O. Deutsch
YHYaron Haviv
Yaron Haviv
GKG. Krief
G. Krief
NKN. Keshet
N. Keshet
RWR. Westreich
R. Westreich
APA. Palmon
A. Palmon
The 80% mortality rate of pancreatic-cancer (PC) makes early diagnosis a challenge. Oral fluids (OF) may be considered the ultimate body fluid for non-invasive examinations. We have developed techniques to improve visualization of minor OF proteins thereby overcoming major barriers to using OF as a diagnostic fluid. The aim of this study was to establish a short discriminative panel of OF biomarkers for the detection of PC. Unstimulated OF were collected from PC patients and controls (n = 30). High-abundance-proteins were depleted and the remaining proteins were analyzed by two-dimensional-gel-electrophoresis and quantitative dimethylation-liquid-chromatography-tandem mass-spectrometry. Label-free quantitative-mass-spectrometry analysis (qMS) was performed on 20 individual samples (n = 20). More than 100 biomarker candidates were identified in OF samples, and 21 had a highly differential expression profile. qMS analysis yielded a ROC-plot AUC value of 0.91 with 90.0% sensitivity and specificity for a combination of five biomarker candidates. We found a combination of five biomarkers for PC. Most of these proteins are known to be related to PC or other gastric cancers, but have never been detected in OF. This study demonstrates the importance of novel OF depletion methodologies for increased protein visibility and highlights the clinical applicability of OF as a diagnostic fluid.

1 August 2021 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
DBDana Braiman
Dana Braiman
YKYuval Konstantino
Yuval Konstantino
RWRoi Westreich
Roi Westreich
Background: Herpes simplex virus (HSV) encephalitis is a known cause of cognitive deterioration, neurological disturbances, and seizures though are rarely associated with sinus node dysfunction. Case summary: We present a 54-year-old man admitted to the hospital with a 10-day history of fever, confusion, and fatigue, 1 week following a transient loss of consciousness. An initial workup suggested HSV encephalitis and the patient was started on intravenous Acyclovir. Due to his episode of syncope, a 24 h Holter electrocardiogram monitoring was performed. The Holter documented multiple episodes of sinus arrest, with a second episode of syncope noticed by the hospital staff concurrent with the last documented sinus arrest. Following antiviral treatment and resolution of the encephalitis we noticed complete resolution of sinus node dysfunction. We subsequently avoided permanent pacemaker implantation. Discussion: Our case of proven HSV encephalitis complicated by sinus node arrest and syncope with complete resolution following antiviral treatment suggests no indication for permanent pacemaker implantation. This approach is consistent with data from previously reported cases.

5 June 2023 in Coronary Artery Disease
Verified
Journal Article
Closed access
RWRoi Westreich
Roi Westreich
GTGal Tsaban
Gal Tsaban
YNYoav Neumann
Yoav Neumann
ASAmjad Abu Salman
Amjad Abu Salman
OBOmri Braver
Omri Braver
YAYigal Abramowitz
Yigal Abramowitz
Introduction: Cardiac troponin (cTn) is the biomarker of choice for detection of myocardial injury. There is a great need for simple point-of-care (POC) troponin testing among patients with chest pain, mainly in the prehospital setting. The purpose of this study was to evaluate the presence of cardiac troponin I (cTnI) in saliva of patients with myocardial injury using alpha-amylase depletion technique. Methods: Saliva samples were collected from 40 patients with myocardial injury who were tested positive for conventional high-sensitivity cardiac troponin T (cTnT) blood tests, and from 66 healthy volunteers. Saliva samples were treated for the removal of salivary alpha-amylase. Treated and untreated samples were tested with blood cTnI Rapid Diagnostic Test. Salivary cTnI levels were compared to blood cTnT levels. Results: Thirty-six of 40 patients with positive blood cTnT had positive salivary samples for cTnI following alpha-amylase depletion treatment (90.00% sensitivity). Moreover, three of the four negative saliva samples were obtained from patients with relatively low blood cTnT levels of 100 ng/L or less (96.88% sensitivity for 100 ng/L and above). The negative predictive value was 93.65% and rose up to 98.33% considering the 100 ng/L cutoff. Positive predictive values were 83.72% and 81.58%, respectively. Among 66 healthy volunteers and 7 samples yielded positive results (89.39% specificity). Conclusion: In this preliminary work, the presence of cTnI in saliva was demonstrated for the first time to be feasibly identified by a POC oriented assay. The specific salivary alpha-amylase depletion technique was shown to be crucial for the suggested assay.

1 December 2019 in JACC: Case Reports
Verified
Journal Article
Open access
RWRoi Westreich
Roi Westreich
MHMoti Haim
Moti Haim
SBSergiy Bereza
Sergiy Bereza
YKYuval Konstantino
Yuval Konstantino
We discuss an unusual case of a patient who initially presented with apparent commotio cordis but returned several months later with spontaneous wide complex tachycardia. This case highlights the importance of investigation of survivors of commotio cordis, especially if atypical, to determine if there is underlying cardiac disease. (Level of Difficulty: Beginner.)


6 September 2026 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
DODaniel Ostrovsky
Daniel Ostrovsky
HAHilmi Alnsarsra
Hilmi Alnsarsra
DSDavid Shamia
David Shamia
RWRoi Westreich
Roi Westreich
ASArtyom Star
Artyom Star
Gal TsabanGal Tsaban
Gal Tsaban
Aims: The comparative association of sodium–glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) with incident atrial fibrillation (AF) or atrial flutter remains uncertain, particularly with early use of both classes. We compared three initial treatment strategies in adults with Type 2 diabetes. Methods and results: We emulated a three-arm target trial using population-based healthcare data from 2015 to 2025. Participants were assigned to SGLT2i without GLP-1RA, GLP-1RA without SGLT2i, or early combined therapy according to dispensings during a 30-day treatment-assignment period. Follow-up began at the end of this period using a landmark design. Treatment groups were balanced using inverse probability of treatment weighting, and cumulative incidence was estimated using weighted Aalen–Johansen methods accounting for competing mortality. Among 216 293 participants, 114 572 received SGLT2i without GLP-1RA, 91 524 received GLP-1RA without SGLT2i, and 10 197 received early combined therapy. At 5 years, cumulative AF or atrial flutter incidence was 4.3%, 4.8%, and 4.2% among participants receiving SGLT2i without GLP-1RA, GLP-1RA without SGLT2i, and early combined therapy, respectively. Sodium–glucose cotransporter-2 inhibitors without GLP-1RA were associated with lower risk than GLP-1RA without SGLT2i [relative risk (RR) 0.88, 95% CI 0.83–0.94], while risk was similar between SGLT2i without GLP-1RA and combined therapy (RR 1.00, 95% CI 0.84–1.19). Conclusion: Among adults with Type 2 diabetes, treatment strategies incorporating SGLT2i were associated with a lower risk of incident AF or atrial flutter than GLP-1RA without SGLT2i. These findings extend the cardiovascular evidence supporting SGLT2i and provide new comparative data regarding early combined use of SGLT2i and GLP-1RA.